These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26590387)

  • 1. Potential compounds for the treatment of mitochondrial disease.
    Rai PK; Russell OM; Lightowlers RN; Turnbull DM
    Br Med Bull; 2015; 116():5-18. PubMed ID: 26590387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.
    Burchell VS; Gandhi S; Deas E; Wood NW; Abramov AY; Plun-Favreau H
    Expert Opin Ther Targets; 2010 Apr; 14(4):369-85. PubMed ID: 20184395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases.
    Whitaker RM; Corum D; Beeson CC; Schnellmann RG
    Annu Rev Pharmacol Toxicol; 2016; 56():229-49. PubMed ID: 26566156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies for mitochondrial diseases and current clinical trials.
    El-Hattab AW; Zarante AM; Almannai M; Scaglia F
    Mol Genet Metab; 2017 Nov; 122(3):1-9. PubMed ID: 28943110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pharmacological strategies for mitochondrial disorders.
    Kanabus M; Heales SJ; Rahman S
    Br J Pharmacol; 2014 Apr; 171(8):1798-817. PubMed ID: 24116962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological advances in mitochondrial therapy.
    Singh A; Faccenda D; Campanella M
    EBioMedicine; 2021 Mar; 65():103244. PubMed ID: 33647769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of drug-based neuroprotection targeting mitochondria.
    Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
    Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial medicine: pharmacological targeting of mitochondria in disease.
    Armstrong JS
    Br J Pharmacol; 2007 Aug; 151(8):1154-65. PubMed ID: 17519949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases.
    Dai CQ; Luo TT; Luo SC; Wang JQ; Wang SM; Bai YH; Yang YL; Wang YY
    J Bioenerg Biomembr; 2016 Aug; 48(4):337-47. PubMed ID: 27422544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.
    Kamat PK; Kalani A; Kyles P; Tyagi SC; Tyagi N
    Cell Biochem Biophys; 2014 Nov; 70(2):707-19. PubMed ID: 24807843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.
    Di Nottia M; Verrigni D; Torraco A; Rizza T; Bertini E; Carrozzo R
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting autophagy and mitophagy for mitochondrial diseases treatment.
    Villanueva Paz M; Cotán D; Garrido-Maraver J; Cordero MD; Oropesa-Ávila M; de La Mata M; Delgado Pavón A; de Lavera I; Alcocer-Gómez E; Sánchez-Alcázar JA
    Expert Opin Ther Targets; 2016; 20(4):487-500. PubMed ID: 26523761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.
    Scatena R; Bottoni P; Botta G; Martorana GE; Giardina B
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C12-21. PubMed ID: 17475665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted nanoparticles in mitochondrial medicine.
    Pathak RK; Kolishetti N; Dhar S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):315-29. PubMed ID: 25348382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial medicine for neurodegenerative diseases.
    Du H; Yan SS
    Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.
    Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G
    Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repairing Mitochondrial Dysfunction in Disease.
    Sorrentino V; Menzies KJ; Auwerx J
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():353-389. PubMed ID: 28961065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial metals as a potential therapeutic target in neurodegeneration.
    Grubman A; White AR; Liddell JR
    Br J Pharmacol; 2014 Apr; 171(8):2159-73. PubMed ID: 24206195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.